Mucaltin tablets 50 mg No. 10x3

Mucaltin 50 mg No. 30 tablet.

Instructions for medical use of the drug Mucaltin® Trade name Mucaltin® International nonproprietary name No Dosage form Tablets 50 mg Composition One tablet contains the active substance: marshmallow medicinal extract dry (Mukaltin) 50.00 mg, excipients: tartaric acid, Effer-Soda® 12, microcrystalline cellulose, calcium stearate. Description Tablets from cream to brown in color with dark and light inclusions, flat-cylindrical in shape, with a chamfer. Pharmacotherapeutic group Drugs to eliminate the symptoms of colds and coughs. Expectorants. ATC code R05CA Pharmacological properties Mucaltin® is a mixture of polysaccharides from the marshmallow herb and has expectorant properties. Thanks to reflex stimulation, it increases the activity of the ciliated epithelium and the peristalsis of the respiratory bronchioles in combination with increased secretion of the bronchial glands. Sodium bicarbonate thins mucus and slightly increases bronchial secretion. Indications for use Acute and chronic diseases of the respiratory tract, accompanied by the formation of difficult to separate sputum of high viscosity: - obstructive bronchitis - tracheobronchitis - pneumoconiosis - bronchiectasis - pneumonia - emphysema Method of administration and dosage Adults and children over 6 years of age, take 1-2 tablets before use food 3-4 times a day. The course of treatment is usually 7-14 days. For children, you can dissolve a tablet of the drug in 1/3 glass of warm water. Side effects - allergic reaction in the form of skin rash, itching - dyspepsia, nausea Contraindications - hypersensitivity to the components of the drug - peptic ulcer of the stomach and duodenum - children under 6 years of age Drug interactions Mucaltin® can be prescribed simultaneously with other drugs used in the treatment of bronchopulmonary diseases. Mucaltin® should not be used simultaneously with drugs containing codeine and other antitussive drugs, as this makes it difficult to cough up liquefied sputum. Special instructions Pregnancy and lactation Use during pregnancy and lactation is possible only in cases where the expected benefit to the mother outweighs the potential risk to the fetus or child. Peculiarities of the drug's influence on the ability to drive vehicles or potentially dangerous mechanisms Does not affect. Overdose Symptoms: nausea, vomiting. Treatment: drug withdrawal, symptomatic therapy. Release form and packaging 10 tablets in a contour cellless package made of combined four-layer paper or 10 tablets in a contour cell package made of polyvinyl chloride/polyvinylidene chloride (PVC/PVDC) film and aluminum foil. Contour cellless packaging is placed in cardboard boxes. Approved instructions for medical use in the state and Russian languages are included in each box according to the number of packages. 3 blister packs together with approved instructions for medical use in the state and Russian languages are placed in a cardboard pack. Packages with packages are placed in a cardboard box. It is allowed to place contour blister packs (without enclosing them in a pack), together with approved instructions for medical use in the state and Russian languages, in cardboard boxes. Information from the approved instructions for medical use in the state and Russian languages is allowed to be applied to the packaging. Storage conditions Store in a dry place, protected from light, at a temperature not exceeding 25°C. Keep out of the reach of children! Shelf life: 2 years Do not use after expiration date. Conditions for dispensing from pharmacies Without a prescription Name and country of the manufacturing organization/packer Khimpharm JSC, Republic of Kazakhstan, Shymkent, st. Rashidova, 81 Name and country of the owner of the registration certificate JSC "Khimpharm", Republic of Kazakhstan, Shymkent, st. Rashidova, 81 Name, address and contact details of the organization that accepts claims (suggestions) from consumers regarding the quality of products (products) on the territory of the Republic of Kazakhstan: Khimpharm JSC, Republic of Kazakhstan, Shymkent, st. Rashidova, 81 Telephone number +7 7252 (610151) Email address Name, address and contact details of the organization in the territory of the Republic of Kazakhstan responsible for post-registration monitoring of the safety of the drug Khimpharm JSC, Republic of Kazakhstan, Shymkent, st. Rashidova, 81

Mukaltin

Registration number: LP-001012
Trade name of the drug: Mucaltin.

International non-proprietary or generic name: Marshmallow herbal extract dry.

Dosage form: Tablets.

Composition (per tablet): Active substances:

Mucaltin dry extract - 50.0 mg (marshmallow herbal extract dry with a total polysaccharide content of at least 18% in terms of glucose)

Excipients - to obtain a tablet weighing 0.3 g:

Sodium bicarbonate - 87.0 mg
Tartaric acid - 159.5 mg
Plasdon K-90 – 0.5 mg
Calcium stearate monohydrate (calcium stearate 1-water) - 3.0 mg

Description: Tablets from light gray to brownish-gray in color, with inclusions, with a specific odor, round, flat-cylindrical in shape with a chamfer on both sides and a score on one side. Inhomogeneity of coloring of the surface of the tablets is allowed.

Pharmacotherapeutic group: Expectorant of plant origin.

ATX code: R05CA

Pharmacological properties: Mucaltin (marshmallow herb extract) contains a mixture of polysaccharides. It has expectorant properties - due to reflex stimulation, it enhances the activity of the ciliated epithelium and the peristalsis of the respiratory bronchioles in combination with increased secretion of the bronchial glands.

Indications for use: Acute and chronic diseases of the respiratory tract, accompanied by a cough with difficult to separate sputum of high viscosity (including tracheobronchitis, obstructive bronchitis, bronchiectasis, pneumonia) - as part of complex therapy.

Contraindications:

Hypersensitivity to the components of the drug
Peptic ulcer of the stomach and duodenum
Children's age up to 12 years

Use during pregnancy and breastfeeding: The use of the drug is indicated if the potential benefit to the mother outweighs the possible risk to the fetus and child. You must consult your doctor!

Directions for use and dosage: Inside. Adults and children over 12 years old: 1 - 2 tablets 2 - 3 times a day before meals. The course of treatment is 7 - 14 days. For children, you can dissolve the tablet in 1/3 glass of warm water.

Side effects: Dyspeptic symptoms and allergic reactions are possible.

Overdose: To date, no cases of overdose have been registered with the use of the drug.

Interaction with other drugs: Mucaltin can be prescribed simultaneously with other drugs used in the treatment of bronchopulmonary diseases. Mucaltin should not be used simultaneously with drugs containing codeine and other antitussive drugs, as this makes it difficult to cough up liquefied sputum.

Effect on the ability to drive vehicles and other mechanisms: No effect.

Release form: Tablets 50 mg. 10 pieces per contour cellless packaging made of packaging paper with a polymer coating. One or two contour cellless packages along with instructions for use are placed in a cardboard pack. It is allowed to place contour cellless packages together with an equal number of instructions for use in a group package. 30 pieces in orange glass jars with or without a desiccant, sealed with perforated aluminum caps. 30 pieces each in polymer cans with a shock absorber and a tensioned lid with first opening control or in polymer cans with a barrier neck with or without a desiccant. Each jar, along with instructions for use, is placed in a cardboard pack.

Storage conditions: Store in a dry place at a temperature not exceeding 20 °C. Keep out of the reach of children.

Shelf life: 2 years. Do not use after the expiration date.

Conditions for dispensing from pharmacies: Without a prescription.

Name

Mukaltin.

Release form

Pills.

Dosage

50 mg. Quantity per package: 30 pcs.

Manufacturer

Galichfarm.

INN

Althea officinalis extract.

FTG

Expectorant of plant origin.

The tablets are grayish-brown in color with inclusions, flat-cylindrical, with a score and a chamfer.

Compound

For one tablet: Active ingredient: mucaltin obtained from the marshmallow herb Althaea officinalis L. (8-12:1) - 50 mg, extractant - drinking water. Excipients: calcium stearate, heavy magnesium carbonate, tartaric acid.

Pharmacotherapeutic group

Expectorants. ATC code R05C A.

Pharmacological properties

Mucaltin is a mixture of polysaccharides from the herb marshmallow. The drug has enveloping and expectorant properties.

Indications for use

In the complex therapy of inflammatory diseases of the respiratory tract accompanied by cough.

Directions for use and dosage

Adults and children over 12 years old, take 1-2 tablets orally 2-3 times a day before meals. The course of treatment averages 7-14 days. For children, you can dissolve the tablet in ⅓ glass of warm water. The duration of the course of treatment is determined by the doctor, taking into account the characteristics of the disease, tolerability of the drug and the achieved effect.

Side effects

Allergic reactions (rash, urticaria, itchy skin) and dyspeptic symptoms may occur. If adverse reactions occur, including those not indicated in the instructions for use, you must stop taking the drug and consult a doctor.

Contraindications

Hypersensitivity to the components of the drug, peptic ulcer of the stomach and duodenum, children under 12 years of age.

Overdose

With prolonged use or exceeding the indicated doses, nausea and vomiting may occur. In case of overdose, consult a doctor. Treatment is symptomatic.

Precautionary measures

It is advisable to take single doses of the drug every 4 hours. If, while taking the drug, symptoms persist or the condition worsens (temperature rises, breathing problems develop, cough with purulent sputum appears, etc.), you must stop taking the drug and consult a doctor. Children. The medicine should not be used in children under 12 years of age.

Use during pregnancy and lactation

Safety of use during pregnancy and lactation has not been established. Due to the lack of sufficient data, it is not recommended to take during pregnancy and lactation.

The ability to influence the reaction rate when driving vehicles or other mechanisms

Studies have not been conducted to evaluate the effect of taking the drug on the ability to drive a car and operate machinery.

Interaction with other drugs

Do not use simultaneously with antitussive drugs (for example, those containing codeine) and drugs that reduce sputum production.

Conditions and shelf life

Store in original packaging at a temperature not exceeding 25 °C. Keep out of the reach of children. Best before date. 4 years.

Vacation conditions

Over the counter.

Package

10 tablets in a strip of paper laminated with polyethylene. 3 strips together with an insert are placed in a pack. 30 tablets in a plastic container with a tamper evident lid. The free space in the container is filled with medical absorbent cotton. A label is placed on the container. 1 container together with the leaflet is placed in a pack. 10 tablets per blister made of polyvinyl chloride film and aluminum foil with printing, varnished. 3 blisters together with an insert are placed in a pack.

Buy Mucaltin tablet 50 mg in blister pack. in pack No. 10x3 in the pharmacy

Price for Mucaltin tablet 50 mg in blister pack. in pack №10x3

Instructions for use for Mucaltin tablet 50 mg in blister pack. in pack №10x3